Modern Medicine
Ophthalmologists can expect more choices in drug therapies for glaucoma. That is good news for Barbara Wirostko, MD, clinical adjunct associate professor at the University of Utah Moran Eye Center, Salt Lake City, UT, who co-moderated a session on new outflow drugs.